BF Biosciences Limited (PSX:BFBIO)

BF Biosciences Balance Sheet

Financials in millions PKR. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	197.72	278.77	255.44	211.67	421.69	28.95
Short-Term Investments	77.3	39.01	147.39	1,498	848.82	502.2
Cash & Short-Term Investments	2,073	317.78	402.83	1,710	1,271	531.15
Cash Growth	414.57%	-21.11%	-76.44%	34.58%	139.20%	11.42%
Accounts Receivable	272.69	204.61	93.81	52.71	202.49	49.2
Other Receivables	-	49.33	49.64	-	-	-
Receivables	272.69	253.94	143.45	67.93	230.01	70.49
Inventory	1,483	893.81	852.24	406.55	356.16	236.35
Prepaid Expenses	-	5.88	2.28	-	-	-
Other Current Assets	241.01	205.26	190.5	110.93	98.97	74.17
Total Current Assets	4,070	1,677	1,591	2,295	1,956	912.16
Property, Plant & Equipment	4,312	4,175	4,070	2,135	1,034	117.45
Other Intangible Assets	5.11	0.55	1.11	-	-	-
Long-Term Deferred Tax Assets	-	-	-	-	-	13.56
Other Long-Term Assets	7.83	7.83	4.83	4.83	4.83	4.55
Total Assets	8,395	5,860	5,667	4,435	2,995	1,048
Accounts Payable	1,211	281.74	225.38	394.28	401.74	201.63
Accrued Expenses	39.18	253.41	144.7	13.82	6.74	0.04
Short-Term Debt	239.14	328.7	473.39	149.35	-	-
Current Portion of Long-Term Debt	320.49	292.72	356.88	57.65	16.32	1.75
Current Unearned Revenue	166.28	150.87	135.59	99.86	41.6	56.68
Other Current Liabilities	-	121.15	67.02	-	-	-
Total Current Liabilities	1,976	1,429	1,403	714.96	466.4	260.09
Long-Term Debt	1,520	1,591	1,772	1,537	873.06	4.98
Long-Term Unearned Revenue	373.96	432.6	503.73	331.33	172.67	0.27
Long-Term Deferred Tax Liabilities	113.58	48.31	13.51	26.55	15.99	-
Total Liabilities	3,984	3,500	3,693	2,610	1,528	265.34
Common Stock	265	190	190	190	190	190
Retained Earnings	2,365	2,170	1,784	1,502	1,200	592.37
Comprehensive Income & Other	-	-	-	132.7	76.27	-
Shareholders' Equity	4,411	2,360	1,974	1,825	1,467	782.37
Total Liabilities & Equity	8,395	5,860	5,667	4,435	2,995	1,048
Total Debt	2,080	2,212	2,603	1,744	889.38	6.73
Net Cash (Debt)	-6.86	-1,894	-2,200	-34.26	381.13	524.42
Net Cash Growth	-	-	-	-	-27.32%	14.87%
Net Cash Per Share	-0.10	-29.91	-34.74	-0.54	6.02	8.28
Filing Date Shares Outstanding	88.33	63.33	63.33	63.33	63.33	63.33
Total Common Shares Outstanding	88.33	63.33	63.33	63.33	63.33	63.33
Working Capital	2,093	248.08	188.34	1,580	1,489	652.07
Book Value Per Share	49.93	37.26	31.17	28.82	23.16	12.35
Tangible Book Value	4,406	2,359	1,973	1,825	1,467	782.37
Tangible Book Value Per Share	49.87	37.25	31.15	28.82	23.16	12.35
Land	-	25.36	25.36	-	-	-
Buildings	-	236.06	214.16	-	-	-
Machinery	-	1,191	708.94	-	-	-
Construction In Progress	75.43	3,516	3,884	-	-	-

Updated Feb 28, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.